McKesson (MCK) Segment Reporting, Other Segment Item, Amount — Quarterly & Annual

Screener

Segment Reporting, Other Segment Item, Amount at other companies

ConocoPhillipsCOP

$7.45B+42.3%

PRA GroupPRAA

$35.48M-6.5%

Matthews InternationalMATW

-$15.63M-883%

Collegium Pharmaceutical, Inc.COLL

$25.48M+4,316%

Radiant LogisticsRLGT

-$271K-113%

Microbot MedicalMBOT

$557K+7.3%

Segments

By segment

North American Pharmaceutical$85.87B—

Oncology & Multispecialty$13.9B—

Medical-Surgical Solutions$2.7B+8.8%

Prescription Technology Solutions$1.34B+13.5%

Other financials

Income statement

Revenue$105.38B+7.7%

Gross profit$3.7B+12.4%

Operating income$1.3B+27.3%

Net income$614.0M-21.7%

EPS (diluted)$5.15-17.6%

Balance sheet

Cash & equivalents$5.3B+95.9%

Total debt$13.0B+15.7%

Total equity-$4.2B-116%

Total assets$88.3B+8.6%

Cash flow

Operating cash flow-$220.0M+76.0%

CapEx$112.0M+0.9%

Free cash flow-$332.0M+67.7%

Valuation

Market cap$101.59B+15.6%

Enterprise value$109.31B+13.4%

P/E22.1×-5.7×

P/S0.3×0.0×

Profitability

Gross margin3.6%+0.1pp

Operating margin1.6%+0.4pp

Net margin1.1%+0.3pp

FCF margin1.6%0.0pp

Returns & leverage

Return on equity36%—

Debt / equity2×—

Current ratio0.9×0.0×